首页> 美国卫生研究院文献>Neuropsychiatric Disease and Treatment >Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

【2h】

Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

机译：帕潘立酮棕榈酸酯每月一次的启动时间对住院的精神分裂症急性加重亚洲患者的影响：PREVAIL研究的事后分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeTo evaluate the differences in efficacy and safety outcomes in acute exacerbating schizophrenia patients between 2 subgroups (≤1 week and >1 week), differing in time interval from hospitalization to time of initiation of once-monthly paliperidone palmitate.

机译：目的评估急性加重型精神分裂症患者在两个亚组（≤1周且> 1周）之间的疗效和安全性结果的差异，从住院到每月一次帕潘立酮棕榈酸酯开始治疗的时间间隔不同。

著录项

期刊名称 Neuropsychiatric Disease and Treatment
作者
Huafang Li; Yan Li; Yu Feng; Jianmin Zhuo; Ibrahim Turkoz; Maju Mathews; Wilson Tan;
展开▼
作者单位

展开▼
年(卷),期 2018(14),-1
年度 2018
页码 1107–1117
总页数 11
原文格式 PDF
正文语种
中图分类神经病学;精神病学;
关键词
early treatment initiation hospital setting long acting injectable Asian hospital discharge efficacy safety positive and negative syndrome scale total score;

机译：早期治疗开始;医院环境;长效注射剂;亚洲人;出院;疗效;安全性;阳性和阴性综合征量表总分;

相似文献

外文文献
中文文献
专利

1. Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study [J] . Huafang Li, Yan Li, Yu Feng, Neuropsychiatric Disease and Treatment . 2018,第1期

机译：帕潘立酮棕榈酸酯每月一次的启动时间对住院的精神分裂症急性加重亚洲患者的影响：PREVAIL研究的事后分析
2. Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study [J] . HuaFang Li, Ibrahim Turkoz, Fan Zhang Neuropsychiatric Disease and Treatment . 2015,第1期

机译：每月一次注射帕潘立酮棕榈酸酯治疗亚洲急性加重性精神分裂症患者的疗效和安全性：一项开放性，前瞻性，非对照研究
3. Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study [J] . HuaFang Li, Ibrahim Turkoz, Fan Zhang Neuropsychiatric Disease and Treatment . 2015,第1期

机译：每月一次注射帕潘立酮棕榈酸酯治疗亚洲急性加重性精神分裂症患者的疗效和安全性：一项开放性，前瞻性，非对照研究
4. Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label prospective noncomparative study [O] . HuaFang Li, Ibrahim Turkoz, Fan Zhang 2016

机译：每月一次注射帕潘立酮棕榈酸酯对亚洲住院的急性加重性精神分裂症患者的疗效和安全性：一项开放性前瞻性非对照研究
5. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study. [O] . Steven G Potkin, Jean-Yves Loze, Carlos Forray, 2017

机译：阿立哌唑每月一次的反应与帕潘立酮棕榈酸酯对精神分裂症的工作准备和功能的关系：QUaLIFY研究的事后分析。

Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅